Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a large, diverse list of new locations and institutions across many countries, expanding the scope of a study/recruiting network. Removed several existing locations and some specific hospitals and cities, reducing prior coverage. Overall, the page now features a broader international network of sites while eliminating a subset of previously listed sites.
    Difference
    15%
    Check dated 2025-10-09T01:04:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a new contact number and a new revision tag; removed a specific older resource entry and an older revision tag. This indicates updated contact information and software versioning, with some content cleanup.
    Difference
    0.2%
    Check dated 2025-10-01T04:59:49.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    - Added a new contact number and a newer revision tag (v3.1.0). - Removed a specific disease resource (Ovarian cancer) and the older revision tag (v3.0.2).
    Difference
    0.2%
    Check dated 2025-09-30T03:24:45.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; the v3.0.1 reference and a Back to Top element were removed. No substantive changes to core content, pricing, stock, or time-slot availability.
    Difference
    0.1%
    Check dated 2025-09-15T19:31:48.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-08T15:09:08.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, particularly for various regions in South Korea, Argentina, Belgium, China, Germany, France, Japan, Israel, Poland, and Turkey. Additionally, the page now features updated publications related to ovarian cancer and resources from the Genetic and Rare Diseases Information Center.
    Difference
    16%
    Check dated 2025-09-01T09:40:46.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.